Market Place
Sourcing Support
Epclusa`s fast-tracked Chinese approval might be late for Gilead
31 May 2018 //
FIERCE PHARMA
Opdivo, Repatha and Lynparza likely among China’s 2018 blockbuster nods: report
06 Jan 2018 //
FIERCE PHARMA
Recent Success in HCV Treatment Brings Relief to Patients
07 Nov 2016 //
DRUG DEVELOPMENT
Japan`s PMDA reviews hep B risk link to hep C therapies
04 May 2016 //
FIERCE ASIA
BMS PhIII hep C combo results a milestone for China plans
22 Feb 2016 //
FIERCE PHARMA ASIA
BMS gets a leg in the China hep C race with PhI for Daklinza
19 Nov 2015 //
FIERCE PHARMA ASIA
AbbVie moves closer to Japan`s crowded hep C field with priority review nod
17 Apr 2015 //
FIERCE PHARMA
Japan pharma market on track for $80B mark by 2020, but obstacles seen
01 Apr 2015 //
FIERCE PHARMA ASIA
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.